NDC 51660-724

Loratadine and Pseudoephedrine

Loratadine And Pseudoephedrine

Loratadine and Pseudoephedrine is a Oral Tablet, Extended Release in the Human Otc Drug category. It is labeled and distributed by Ohm Laboratories Inc.. The primary component is Loratadine; Pseudoephedrine Sulfate.

Product ID51660-724_17d4b57e-a809-46ff-a15c-b5550a37a1c1
NDC51660-724
Product TypeHuman Otc Drug
Proprietary NameLoratadine and Pseudoephedrine
Generic NameLoratadine And Pseudoephedrine
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2004-11-17
Marketing CategoryANDA / ANDA
Application NumberANDA076557
Labeler NameOhm Laboratories Inc.
Substance NameLORATADINE; PSEUDOEPHEDRINE SULFATE
Active Ingredient Strength10 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 51660-724-04

3 BLISTER PACK in 1 CARTON (51660-724-04) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Start Date2004-11-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51660-724-15 [51660072415]

Loratadine and Pseudoephedrine TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076557
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2004-11-17
Inactivation Date2020-01-31

NDC 51660-724-69 [51660072469]

Loratadine and Pseudoephedrine TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076557
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2004-11-17
Inactivation Date2020-01-31

NDC 51660-724-56 [51660072456]

Loratadine and Pseudoephedrine TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076557
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2004-11-17
Inactivation Date2020-01-31

NDC 51660-724-05 [51660072405]

Loratadine and Pseudoephedrine TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076557
Product TypeHUMAN OTC DRUG
Marketing Start Date2004-11-17
Marketing End Date2013-04-19

NDC 51660-724-30 [51660072430]

Loratadine and Pseudoephedrine TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076557
Product TypeHUMAN OTC DRUG
Marketing Start Date2004-11-17
Marketing End Date2013-04-19

NDC 51660-724-11 [51660072411]

Loratadine and Pseudoephedrine TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076557
Product TypeHUMAN OTC DRUG
Marketing Start Date2004-11-17
Marketing End Date2013-04-19

Drug Details

Active Ingredients

IngredientStrength
LORATADINE10 mg/1

OpenFDA Data

SPL SET ID:556b89ef-3b51-4faa-afb4-767a5c1b6422
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1117562
  • Medicade Reported Pricing

    51660072469 ALLERGY RELIEF-NASAL DECONG TB

    Pricing Unit: EA | Drug Type:

    51660072415 ALLERGY RELIEF-NASAL DECONG TB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Loratadine and Pseudoephedrine" or generic name "Loratadine And Pseudoephedrine"

    NDCBrand NameGeneric Name
    0363-0725Loratadine and PseudoephedrineLoratadine and Pseudoephedrine
    11822-9990Loratadine and PseudoephedrineLORATADINE and PSEUDOEPHEDRINE SULFATE
    21695-729Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    41163-165Loratadine and PseudoephedrineLoratadine and Pseudoephedrine
    46122-383Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    51660-488Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    51660-491Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    51660-724Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    61715-016Loratadine and PseudoephedrineLoratadine and Pseudoephedrine
    63187-305Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    63629-7766Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    70518-0653Loratadine and Pseudoephedrineloratadine and pseudoephedrine
    59779-726ALLERGY RELIEF-DLoratadine and Pseudoephedrine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.